Reyon Pharm (102460)

Seoul
32,150.00
+7,400.00(+29.90%)
  • Volume:
    1
  • Bid/Ask:
    32,150.00/0.00
  • Day's Range:
    25,000.00 - 32,150.00

102460 Overview

Prev. Close
24,750
Day's Range
25,000 - 32,150
Revenue
130.03B
Open
25,300
52 wk Range
13,137 - 32,150
EPS
217.84
Volume
1
Market Cap
411.9B
Dividend (Yield)
196.08 (0.85%)
Average Vol. (3m)
196,372
P/E Ratio
105.58
Beta
1.5
1-Year Change
86.34%
Shares Outstanding
17,666,670
Next Earnings Date
-
What is your sentiment on Reyon Pharm?
or
Market is currently closed. Voting is open during market hours.

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesBuyBuyStrong BuyStrong BuyStrong Buy
Technical IndicatorsNeutralBuyStrong BuyStrong BuyStrong Buy
SummaryNeutralBuyStrong BuyStrong BuyStrong Buy

Reyon Pharm Company Profile

Reyon Pharm Company Profile

Employees
361

REYON PHARMACEUTICAL Co. Ltd. is a Korea-based company engaged in the provision of pharmaceutical products. The Company’s products consist of remedies for circulatory systems, endocrine systems, digestive systems, respiratory systems, urinary systems and nervous systems, as well as eye drops, antibiotics, fever reducers, painkillers, anti-inflammatory drugs, antihistaminic agents, enzyme preparations, arthritis remedies, antitumor drugs and topical anesthetics, among others. It also produces pharmaceutical raw materials, such as arbekacin sulfate, alibendol, carvedilol, enocitabine, gemcitabine, glimepiride, lamotrigine, meloxicam, oxaliplatin, pioglitazone hydrochloride, ramipril, streptokinase, tacrolimus, thioctic acid, teicoplanin, voglibose and others.

Read More
  • amazing!
    0
    Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All derived (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data.
    Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.